Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
GMDS divergent transcript | 0.861 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2016 | 2016 | |||||||||
|
BORCS7-ASMT readthrough (NMD candidate) | 0.805 | 0.154 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
long intergenic non-protein coding RNA 1993 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||||
|
cortexin domain containing 2 | 1.000 | 0.038 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
TSBP1 and BTNL2 antisense RNA 1 | 0.638 | 0.692 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
long intergenic non-protein coding RNA 1752 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||||
|
PIK3IP1 antisense RNA 1 (head to head) |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||||
|
OSMR antisense RNA 1 (head to head) | 1.000 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
long intergenic non-protein coding RNA 1222 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||||
|
long intergenic non-protein coding RNA 1221 | 1.000 | 0.038 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
TMEM72 antisense RNA 1 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||||
|
coiled-coil domain containing 162, pseudogene | 0.890 | 0.154 |
|
phenotype | 0.100 | None | 1.000 | 1 | 4 | 2016 | 2016 | |||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
long intergenic non-protein coding RNA 877 |
|
phenotype | 0.100 | None | 1.000 | 1 | 3 | 2016 | 2016 | |||||||||||
|
hemoglobin subunit zeta pseudogene 1 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||||
|
major histocompatibility complex, class I, L (pseudogene) | 0.861 | 0.269 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
HLA complex group 18 | 0.722 | 0.538 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2016 | 2016 | |||||||||
|
HLA complex group 17 | 0.769 | 0.346 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2016 | 2016 | |||||||||
|
MIR4435-2 host gene | 0.604 | 0.692 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2016 | 2016 | |||||||||
|
MIR3936 host gene | 0.861 | 0.269 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2016 | 2016 | |||||||||
|
tetratricopeptide repeat domain 25 | 0.674 | 0.538 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
dynein axonemal heavy chain 10 | 0.890 | 0.154 | 1.4E-57 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
laminin subunit alpha 3 | 0.576 | 0.731 | 8.8E-46 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
THADA armadillo repeat containing | 0.686 | 0.500 | 4.6E-41 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
solute carrier family 22 member 16 | 0.626 | 0.500 | 6.3E-27 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 |